Skip to main content
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 2012 Mar 13;89(3):527–564. doi: 10.1007/s11524-012-9670-1

Estimates of the Population Prevalence of Injection Drug Users among Hispanic Residents of Large US Metropolitan Areas

Enrique R Pouget 1,, Samuel R Friedman 1, Charles M Cleland 2, Barbara Tempalski 1, Hannah L F Cooper 3
PMCID: PMC3368042  PMID: 22411420

Abstract

Little information exists on the population prevalence or geographic distribution of injection drug users (IDUs) who are Hispanic in the USA. Here, we present yearly estimates of IDU population prevalence among Hispanic residents of the 96 most populated US metropolitan statistical areas (MSAs) for 1992–2002. First, yearly estimates of the proportion of IDUs who were Hispanic in each MSA were created by combining data on (1) IDUs receiving drug treatment services in Substance Abuse and Mental Health Services Administration (SAMHSA)’s Treatment Entry Data System, (2) IDUs being tested in the Centers for Disease Control and Prevention (CDC) HIV-Counseling and Testing System, and (3) incident AIDS diagnoses among IDUs, supplemented by (4) data on IDUs who were living with AIDS. Then, the resulting proportions were multiplied by published yearly estimates of the number of IDUs of all racial/ethnic groups in each MSA to produce Hispanic IDU population estimates. These were divided by Hispanic population data to produce population prevalence rates. Time trends were tested using mixed-effects regression models. Hispanic IDU prevalence declined significantly on average (1992 mean = 192, median = 133; 2002 mean = 144, median = 93; units are per 10,000 Hispanics aged 15–64). The highest prevalence rates across time tended to be in smaller northeastern MSAs. Comparing the last three study years to the first three, prevalence decreased in 82% of MSAs and increased in 18%. Comparisons with data on drug-related mortality and hepatitis C mortality supported the validity of the estimates. Generally, estimates of Hispanic IDU population prevalence were higher than published estimates for non-Hispanic White residents and lower than published estimates for non-Hispanic Black residents. Further analysis indicated that the proportion of IDUs that was Hispanic decreased in 52% and increased in 48% of MSAs between 2002 and 2007. The estimates resulting from this study can be used to investigate MSA-level social and economic factors that may have contributed to variations across MSAs and to help guide prevention program planning for Hispanic IDUs within MSAs. Future research should attempt to determine to what extent these trends are applicable to Hispanic national origin subgroups.

Keywords: Hispanics/Latinos, Racial/ethnic health disparities, Injection drug use, HIV/AIDS, Drug policy


Hispanic injection drug users (IDUs) are a particularly vulnerable population for a number of reasons. In the USA, IDUs who are Hispanic are more likely to be infected with HIV and hepatitis C than IDUs who are non-Hispanic White.1,2 Hispanics infected with HIV are twice as likely as non-Hispanic Whites to be diagnosed late in the course of their infection.3 Hispanic IDUs may be less likely to utilize HIV prevention services, or services for drug users, than non-Hispanics due to greater concern about stigma regarding drug use, HIV/AIDS, or the association between HIV/AIDS and homosexuality.47

Research on Hispanic IDUs is hampered by the lack of information on their number and geographic location over time. Such information could be used to better target HIV and hepatitis C prevention programs among Hispanic IDUs and to compare trends in injection drug use, HIV, and hepatitis C across racial/ethnic groups. Data on overall IDU prevalence and on IDU prevalence among non-Hispanic White and non-Hispanic Black residents aged 15–64 of the 96 largest US metropolitan statistical areas (MSAs) have been published for the 1992–2002 period.8,9 The current study fills a crucial gap by providing estimates of IDU population prevalence among Hispanic residents aged 15–64 in the same set of MSAs during the same time period. To extend the analysis to more recent years, we also examine change in the estimated proportion of IDUs who were Hispanic from 2002 to 2007.

Methods

We use the term “Hispanic” to indicate self-reported Hispanic or Latino ethnicity to be consistent with our sources of data. The federal Office of Management and Budget (OMB) defines people of Hispanic ethnicity as “persons who trace their origin or descent to Mexico, Puerto Rico, Cuba, Central and South America, and other Spanish cultures.”10 The sources used in this study categorized participants into Hispanic, non-Hispanic Black, non-Hispanic White, and other categories.

We use MSA as the geographic unit of analysis because MSAs are defined by the OMB to represent socially and economically integrated entities, made up of contiguous counties that contain a central city of 50,000 people or more.11 They are likely to reflect social and economic integration among IDUs.12 We obtained yearly estimates of the MSA populations aged 15–64 for Hispanics and for residents of all racial/ethnic groups from publically available Census data.13

To estimate Hispanic IDU prevalence, we multiplied yearly estimates of the proportion of IDUs who were Hispanic (averaging proportions from three sources, described below) in each MSA by yearly published estimates of the number of IDUs of all racial/ethnic groups in each MSA. Since overall IDU prevalence estimates were available for 1992–2002, the timeframe for the current study is also 1992–2002. The calculation is summarized in formula 1.

graphic file with name M1.gif 1

where HIDUij = estimated prevalence of IDUs among Hispanic residents, aged 15–64, in study year i, MSA j; ProportionHij = estimated proportion of IDUs who were Hispanic in study year i, MSA j; IDUNij = published estimated number of IDUs of all racial/ethnic groups, aged 15–64, in study year i, MSA j; PopulationHij = number of residents who were Hispanic, aged 15–64, in study year i, MSA j.

Combining Source Data

The proportions of IDUs who were Hispanic were estimated by combining three data series: (1) HIV-Counseling and Testing Services (CTS),14 (2) Treatment Episode Data Set (TEDS),15 and (3) data on incident AIDS diagnoses among people who reported injection drug use as the route of HIV acquisition, supplemented with data on people living with AIDS who reported injection drug use as the route of HIV acquisition.16

HIV-Counseling and Testing Services

CTS data on IDUs receiving HIV-counseling and testing services were obtained from the CDC by special arrangement.14 We calculated the proportions of IDUs receiving services in CTS data who were Hispanic as an indicator for the proportions of the IDU populations who were Hispanic. Of the 95 MSAs included in analyses of the proportions of IDUs who were Hispanic, 77 contributed CTS data. Complete yearly data were available for 52 MSAs; data were available for some years for 25 additional MSAs. Data were incomplete for three reasons: (1) Some health departments reported only aggregated data that could not be matched geographically to the MSAs in our study, (2) data from cells that contained fewer than five individuals were redacted (removed) by the CDC in order to protect against loss of participant confidentiality, and (3) we excluded existing data for 1 year from two MSAs in order to avoid proportion estimates that could be unreliable due to small numbers of IDUs of all racial/ethnic groups (fewer than 20).

Treatment Episode Data Set

TEDS data indicate the number and characteristics of people entering substance abuse treatment programs that receive funding from the federal government. TEDS data are managed by the Substance Abuse and Mental Health Services Administration (SAMHSA) and are publically available.17 We calculated the proportions of IDUs entering drug treatment in TEDS data who were Hispanic as an indicator for the proportions of the IDU populations who were Hispanic. Of the 95 MSAs included in analyses of the proportions of IDUs who were Hispanic, complete yearly data were available for 88 MSAs, and data were available for some years for three additional MSAs. Data from four MSAs could not be used because route of drug administration (injection or non-injection) was not collected or coded. We excluded data for 1 year in three MSAs in order to avoid proportion estimates that could be unreliable due to small numbers of IDUs of all racial/ethnic groups (fewer than 20).

IDU Incident AIDS Diagnoses and People Living with AIDS

We obtained data representing incident AIDS diagnoses (IAIDS) and people living with AIDS (PLWA) attributed to injection drug use from the CDC by special arrangement. We calculated the proportions of IDUs who were Hispanic in IAIDS data, with adjustment for HIV prevalence (described below), as an indicator for the proportions of the IDU populations who were Hispanic. IAIDS data may be more likely to capture IDUs who did not access HIV-counseling and testing or drug treatment services. However, IAIDS data were sparse in some years in some MSAs. We excluded Hispanic proportion data for some years from 28 MSAs in order to avoid proportion estimates that could be unreliable due to small numbers of IDUs of all racial/ethnic groups (fewer than 20). After this exclusion, yearly Hispanic IDU proportions were available for 52 MSAs and for some years for 32 additional MSAs. Fortunately, PLWA data were more complete and were consistent with IAIDS data (the average Pearson correlation between Hispanic proportions of IDUs in IAIDS and PLWA data across study years was 0.96), so we used the proportion of IDU PLWA who were Hispanic as a proxy where IAIDS data were missing. After filling in these data, 93 of the 95 MSAs included in analyses of the proportions of IDUs who were Hispanic contributed yearly IAIDS data. Hispanic IAIDS data were not available for two MSAs because states in which parts of the MSAs were located did not agree to provide the data by race/ethnicity.

Adjustment of IDU Incident AIDS Diagnoses for the Proportion of IDUs Testing Positive for HIV

The proportion of IDU IAIDS cases that are Hispanic can be influenced by a number of factors, including racial/ethnic differences in HIV prevalence, utilization and effectiveness of HIV counseling and testing and HAART, and other factors related to progression to AIDS. To reduce potential bias due to variation among MSAs in relative HIV prevalence by race/ethnicity, we adjusted the proportion of IDUs who were Hispanic in IAIDS data (PIAIDS) for HIV prevalence among IDUs in CTS data using the following formula:

graphic file with name M2.gif 2

where HijIAIDS = the number of Hispanic IDU IAIDS cases in study year i, MSA j; Hij = the proportion of Hispanic IDUs testing positive for HIV in CTS data in study year i, MSA j; TijIAIDS = the number of IAIDS cases of IDUs of all racial/ethnic groups in study year i, MSA j; Tij = the proportion of IDUs of all racial/ethnic groups testing positive for HIV in CTS data in study year i, MSA j.

This formula assumes that the yearly HIV proportions of Hispanic IDUs and of IDUs of all racial/ethnic groups in who test positive for HIV in CTS data in each MSA reflect HIV prevalence in their respective underlying populations. It is important to note that CTS data represent the number of tests and positive results, not the number of individuals testing positive.

Imputations to Estimate Missing HIV Test Result Data

CTS Data on the proportion testing positive for HIV among Hispanic IDUs and among IDUs of all racial/ethnic groups were incomplete due to inconsistent reporting, removal by the CDC of test result data from small cells (fewer than five positive results) to protect participant confidentiality, and exclusion of data on the proportion positive that would have been based on fewer than 20 Hispanic IDUs.

We imputed values to fill in missing CTS HIV data for Hispanic IDUs in two steps. First, in a binomial mixed-effects regression, we imputed values as a function of (a) year, (b) the proportion of IDUs of all racial/ethnic groups testing positive for HIV, and (c) the proportion of IDUs tested who were Hispanic. Next, in MSAs where Hispanic IDU HIV data were missing for some years, we imputed missing values using predicted values from a linear mixed-effects regression on time. Mixed-effects regressions were performed using the SAS procedure PROC GLIMMIX (version 9.2). We imputed values to fill in missing CTS HIV data for IDUs of all racial/ethnic groups in a parallel manner, using year, the proportion of all CTS clients testing positive for HIV, and the proportion of CTS clients tested who were IDUs as predictors for the mixed-effects binomial regression. We used average values predicted by the binomial regressions of yearly proportions testing positive for HIV among Hispanic IDUs and IDUs of all racial/ethnic groups for 22 of the 93 MSAs contributing IAIDS data because CTS HIV test result data for those MSAs were missing for all study years.

Averaged Proportions of IDUs Who Were Hispanic

We created a complete data set of the proportions of IDUs who were Hispanic from the three data sources—CTS, TEDS, and IAIDS (supplemented with PLWA data and adjusted for HIV prevalence)—using predicted values from a binomial mixed-effects regression. We modeled Hispanic proportions using events/trials syntax with the number of Hispanic IDUs in the numerator and the number of IDUs of all racial/ethnic groups in the denominator.18 Data sources were stacked so that each MSA and year was represented by as many cases as there were data sources (one, two, or all three sources). Data were available from all three sources for 72 MSAs, from any two sources for 18 MSAs, and from only one source for 5 MSAs. The model used all the available data to estimate parameters, even where some data were missing, under the assumption that the data were missing at random, conditional on the observed data. Dummy codes were used to compare data sources. We used a quadratic polynomial model of time to maintain consistency with procedures used to produce the overall IDU estimates.8 Intercepts were set to vary randomly using residual pseudo-likelihood estimation. Standard errors of the fixed effects were adjusted using the sandwich method.18

The resulting complete sets of proportions were averaged to create single yearly estimates of the proportion of IDUs who were Hispanic. These proportions were then multiplied by published estimates of the number of IDUs of all racial/ethnic groups to produce estimates of the Hispanic IDU populations.

Published Population Data for IDUs of All Racial/Ethnic Groups

Procedures used to estimate the populations of IDUs of all racial/ethnic groups in these MSAs are described in detail elsewhere.8 Briefly, we began with annual national estimates of the number of drug treatment entrants who were IDUs, the number of IDUs who were tested for HIV, the number of arrestees for heroin and cocaine possession multiplied by the proportion of treatment entrants treated for heroin or cocaine dependence who reported that they injected drugs, and regression-based interpolations and extrapolations of published estimates for the years 1992 and 1998.19,20 These national estimates were allocated to each MSA using multiplier methods and then smoothed to reduce stochastic variation with locally weighted regression.

Calculating Hispanic IDU Population Prevalence

By multiplying estimates of the proportions of IDUs who were Hispanic by the published estimated numbers of IDUs of all racial/ethnic groups, we created estimates of the numbers of IDUs who were Hispanic. We calculated Hispanic IDU population prevalence by dividing these estimates by their respective Hispanic populations, aged 15–64. We used the published8 prevalence of IDUs of all racial/ethnic groups as the prevalence of IDUs who were Hispanic in the San Juan–Bayamon, Puerto Rico MSA because CTS data were not collected, TEDS data were not collected by race/ethnicity, and IAIDS data indicated that few IDUs with AIDS were non-Hispanic.

Reliability

We assessed reliability of the data with yearly Pearson correlations of the three Hispanic IDU proportions (CTS, TEDS, IAIDS).

Validity

We assessed the validity of the Hispanic IDU prevalence estimates by assessing their correlations with two indicators of Hispanic injection drug use—drug-related mortality and hepatitis C mortality—among Hispanics. Mortality data were extracted from the Multiple Cause of Death data tabulated by the National Vital Statistics System.21 In these data, ICD-9 coding was used to identify causes of death between 1992 and 1998, and ICD-10 coding was used thereafter. Our coding of drug-related deaths was based on that of the European Monitoring Centre for Drugs and Drug Addiction.22 We coded drug-related deaths as “deaths happening shortly after consumption of one or more psychoactive drugs and directly related to this consumption,” and “accidental and unintentional drug poisoning deaths” that occurred after consuming cocaine, heroin, or psychostimulants. Route of drug administration was not used in the ICD coding, so we could not restrict drug-related deaths to those that were IDU-related. We restricted our analysis to deaths that occurred in the MSA of residence. Hepatitis C mortality data were available starting in 1999, when ICD-10 codes to identify hepatitis C (B17.1 and B18.2) were implemented.

Trend Analysis

We used a polynomial mixed-effects model with restricted maximum-likelihood estimation to investigate change in Hispanic IDU prevalence across time among MSAs. Although this selection of MSAs is not, strictly speaking, a sample, we use statistical significance tests as a heuristic guide. We log-transformed Hispanic IDU population prevalence rates before analysis because the rates were right-skewed.

To assess change across time in individual MSAs, we calculated percent change values comparing the earliest (1992–1994) and latest (2000–2002) 3 years of data. We use the average of 3 years to maximize the reliability of the comparisons within MSAs.

To assess trends after the period for which overall IDU prevalence data have been published, we examined the proportion of IDUs that was estimated to be Hispanic. First, we entered the proportions of IDUs who were Hispanic in CTS, TEDS, and IAIDS data from 2002 to 2007 into a polynomial mixed-effects model to assess overall time trends. Then we averaged across the three data series to create an overall estimate of the proportion of IDUs that was Hispanic. Finally, we calculated percent change values comparing proportions averaged over 2002–2004 to those averaged over 2005–2007, the most recent period with available data.

Results

Results from the binomial regression model of the proportions of IDUs who were Hispanic by data source are in Table 1. Anti-logit transforming the intercept gives the average predicted Hispanic proportion value among IAIDS cases—0.061 in 1992. Both the linear (years since 1992) and quadratic (years since 1992 squared) slopes are positive, but only the linear term is significant, indicating a linear increase over time on average. The CTS dummy code was not significant, indicating that Hispanic IDU proportions in CTS data were not different from those in IAIDS data. However, the TEDS dummy code was significant in the positive direction, indicating that TEDS Hispanic IDU proportions were almost 20% higher than those in IAIDS—0.073 on average in 1992.

Table 1.

Binomial mixed-effects regression results for the proportions of injection drug users who were Hispanic in three data sources, 1992–2002

Estimate Standard error
Intercept −2.7336** 0.1667
Years since 1992 0.0132* 0.0060
Years since 1992 squared 0.0008 0.0006
Source
 HIV-Counseling and Testing Services −0.0352 0.0687
 Treatment Episode Data Set 0.1870** 0.0527
 Incident AIDS Diagnoses 1.0
Intercept variance 2.7394 0.4034

N = 96 metropolitan statistical areas

*p < 0.05; **p < 0.01

Pearson correlations among the three estimates of the proportions of IDUs who were Hispanic showed good consistency. Correlations between CTS and TEDS proportions ranged from 0.90 to 0.93 across years (mean = 0.91), while those between CTS and IAIDS ranged from 0.51 to 0.85 (mean = 0.74) and those between TEDS and IAIDS ranged from 0.60 to 0.80 (mean = 0.71).

We calculated a single yearly proportion of IDUs who were Hispanic in each MSA by averaging the set of proportions from the three sources. We multiplied the averaged proportions by published estimates of the populations of IDUs of all racial/ethnic groups and divided the results by the respective Hispanic MSA populations to produce population prevalence estimates.

Descriptive data for the yearly Hispanic IDU population prevalence estimates are in Table 2. The estimates show a substantial decline from 1992 (mean = 192, median = 133) to 2002 (mean = 144, median = 93; units are per 10,000 Hispanics aged 15–64). Hispanic IDU prevalence declined more sharply initially, then more slowly, with fluctuations, forming a slightly curvilinear relationship with time. Figure 1 depicts average IDU prevalence among Hispanic residents, compared with previously published data for non-Hispanic Black and non-Hispanic White residents across time.9 Generally, estimates of Hispanic IDU population prevalence were higher than published estimates for non-Hispanic White residents and lower than published estimates for non-Hispanic Black residents.

Table 2.

Estimated prevalence of Hispanic injection drug users per 10,000 Hispanic residents aged 15–64, 1992–2002

Year Mean SD Minimum Maximum Median IQR
1992 192 189 21 1068 133 68, 239
1993 178 178 16 931 110 58, 232
1994 178 184 16 1070 115 61, 217
1995 168 175 11 905 101 53, 222
1996 162 173 11 874 95 51, 208
1997 158 172 9 840 95 49, 198
1998 155 172 8 807 95 47, 191
1999 154 173 9 915 99 51, 182
2000 148 164 7 787 95 45, 181
2001 147 162 8 865 99 49, 168
2002 144 160 6 809 93 45, 165

N = 96 metropolitan statistical areas

SD standard deviation, IQR interquartile range

Figure 1.

Figure 1.

Average population prevalence of injection drug users by racial/ethnic group and year, 1992–2002. N = 96 metropolitan statistical areas. Data for non-Hispanic White and non-Hispanic Black IDUs were previously published9 and exclude the San Juan, Puerto Rico MSA.

Yearly Pearson correlations with drug-related mortality rates and hepatitis C mortality rates among Hispanics are in Table 3. Correlations with drug-related mortality ranged from 0.36 to 0.62 (mean = 0.48). Correlations with hepatitis C mortality ranged from 0.43 to 0.73 (mean = 0.58).

Table 3.

Pearson correlations of estimated Hispanic injection drug user population prevalence rates with mortality rates for drug-related deaths and hepatitis C deaths among Hispanics, 1992–2002

Drug-related mortality Hepatitis C mortality
1992 0.56
1993 0.62
1994 0.47
1995 0.36
1996 0.45
1997 0.54
1998 0.54
1999 0.50 0.50
2000 0.42 0.43
2001 0.40 0.73
2002 0.41 0.66

N = 96 metropolitan statistical areas

Results of the polynomial mixed-effects model testing for trend over time in logged Hispanic IDU population prevalence rates are in Table 4. The antilog of the intercept, representing Hispanic IDU population prevalence in 1992, is 132.4 Hispanic IDUs per 10,000 Hispanics. The average annual logged linear decline is −0.070; however, the positive polynomial term (0.0028) indicates a flattening of the slope over time. The antilog of the average year-to-year decline, including linear and quadratic terms, was 8.6 per 10,000 from 1992 to 1993 but lessened to 1.4 per 10,000 from 2001 to 2002. The predicted value for 2002 is 87.1 per 10,000, which approximates the observed median estimate.

Table 4.

Linear mixed-effects regression results of logged Hispanic injection drug user population prevalence, 1992–2002

Estimate Standard error
Fixed effects
Intercept 4.8857* 0.0885
Years since 1992 −0.0702* 0.0061
Years since 1992 squared 0.0028* 0.0004
Random effects
Intercept variance 0.7486 0.1091
Years since 1992 variance 0.0028 0.000545
Years since 1992 squared variance 0.00468 0.001968
Residual variance 0.00664 0.000380

N = 96 metropolitan statistical areas

*p < 0.01

The sum of the number of Hispanic IDUs in these MSAs by Census region is presented in Figure 2. An increase in the most recent years of the study period is evident for the northeast region, with less change in the other regions.

Figure 2.

Figure 2.

Sum of Hispanic injection drug users by Census region and year, 1992–2002. N = 96 metropolitan statistical areas.

MSA-specific results are presented in the Appendix. The largest populations of Hispanic IDUs were generally in the MSAs most populated by Hispanics. Averaging the most recent 3 years (2000–2002), the five MSAs with the largest Hispanic IDU populations were Los Angeles–Long Beach, CA (40,375); New York, NY (36,999); San Juan–Bayamon, PR (15,333); Boston, MA–NH (9,872); and San Antonio, TX (9,266). However, the highest IDU prevalence rates among Hispanic residents tended to be in smaller northeastern MSAs. Averaging the most recent 3 years, the five MSAs with the highest prevalence rates (per 10,000 Hispanic residents) were Allentown–Bethlehem–Easton, PA (756); Springfield, MA (752); Hartford, CT (694); Harrisburg–Lebanon–Carlisle, PA (652); and Buffalo–Niagara Falls, NY (533).

We calculated percent change values comparing averages of the earliest (1992–1994) and latest (2000–2002) 3 years of data. Hispanic IDU population prevalence decreased in 79 MSAs—by 10% or more in 70 MSAs and by 50% or more in 13 MSAs. Prevalence increased in 17 MSAs—by 10% or more in eight MSAs (Boston, MA–NH 38%; Baltimore, MD 35%; Honolulu, HI 25%; Toledo, OH and Stockton–Lodi, CA 14%; Pittsburgh, PA and Springfield, MA 12%) and by 50% or more in one MSA (Youngstown–Warren, OH 64%).

Lastly, to extend the analysis to more recent years, for which overall IDU prevalence has not been published, we compared the proportion of IDUs that was Hispanic between 2003 and 2007. This proportion did not change significantly between 2003 and 2007 (linear estimate [Est.] = −0.0057, standard error [SE] = 0.1158; quadratic Est. = 0.0004, SE = 0.0046) across MSAs. We then compared change in the proportion averaged over 2002–2004 to the proportion averaged over 2005–2007 (change could not be estimated for four MSAs with missing data—Gary, IN; San Juan–Bayamon, PR; Tucson, AZ; and Wichita, KS). Of the remaining 92 MSAs, the proportion of IDUs that was Hispanic decreased in 42 (52%) and increased in 44 (48%). Of these 44, 19 increased by more than 10%, and 13 increased by more than 20% (Dayton–Springfield, OH 60%; Greenville–Spartanburg–Anderson, SC 53%; Las Vegas, NV–AZ 49%; New Orleans, LA 45%; Norfolk–Virginia Beach–Newport News, VA–NC 39%; Atlanta, GA 37%; Little Rock–North Little Rock, AR 33%; Richmond–Petersburg, VA 32%; St. Louis, MO–IL 29%; Baltimore, MD 26%; Tacoma, WA 23%; Jacksonville, FL 23%; Detroit, MI 22%).

Discussion

Results from this study greatly expand the data available on Hispanic IDUs in the USA. Multiple sources of data on the proportions of IDUs who were Hispanic showed consistency, and comparisons with data on drug-related mortality and hepatitis C mortality supported the validity of the estimates. Hispanic IDU population prevalence declined from the early 1990s to the early 2000s in most MSAs. This is evident both in trend tests on mean values, in inspection of median and interquartile range values, and in comparisons of early versus late study years within MSAs. A substantial decline in IDU prevalence was previously observed among African American residents of these MSAs on average during this period, while IDU prevalence among non-Hispanic Whites was little changed.9,23 The decline in Hispanic IDU prevalence is similar to the decline in overall IDU prevalence during this time period.8 Mortality from AIDS, overdose, and other causes is likely to have contributed to the reduction in IDU prevalence among Hispanics, just as these causes are likely to have contributed to the reduction in IDU prevalence overall. In addition, the increase in heroin purity, as well as increasing consumption of prescription opioids, may have contributed to the reduction in injecting as a form of drug consumption during this time period.24,25

MSAs with the highest Hispanic IDU prevalence in the years from which the most recent data were available tended to be in the northeast. The ten MSAs with the highest Hispanic IDU prevalence in 2000–2002 were all in Pennsylvania, New York, New Jersey, Massachusetts, or Connecticut. However, MSAs with increasing prevalence were dispersed geographically. MSAs with the largest Hispanic IDU populations across time were also dispersed geographically in MSAs with the largest overall Hispanic populations. More recent data on the proportions of IDUs who were Hispanic showed increases in almost half of the MSAs studied. Research is needed to determine if these increases have translated into increases in Hispanic IDU prevalence and if more recent prevalence trends differ by region.

The extent to which these findings are applicable among Hispanic national origin subgroups is unclear. For example, AIDS cases have been attributed to injecting drugs at a higher proportion among Puerto Rican-born Hispanics than among Hispanics born in the mainland USA or in other countries.2628 According to national treatment data, Puerto Rican clients more often report using opiates than other Hispanic clients on admission,29 and IDUs in Puerto Rico are less likely to utilize drug treatment services than Puerto Rican IDUs in the mainland.30 In addition, injection drug use and risk behaviors have been reported to be more prevalent among Hispanics of Puerto Rican decent, particularly among those born in Puerto Rico, than among Hispanics with origins in Mexico and other countries.3133 Conversely, risk reduction practices have been found to be more frequently reported among Hispanic IDUs of US or Puerto Rican origin than among Hispanics of Mexican origin (particularly those residing in border areas) or other national origin.31,34 Comparing trends in drug use and HIV among Hispanic subgroups in the USA is complicated by the dearth of health data with detailed information regarding national origin and by the large number and diversity of national origin subgroups. Although data on AIDS diagnoses show the distribution of AIDS cases among US Hispanic IDUs by national origin, the lack of population denominators precludes the calculation of prevalence or incidence by national origin, either nationally or by MSA.26 There may also be differences in interpreting survey questions regarding drug use based on national differences in language and stigma regarding drug use that could bias existing data.35

Research is needed to understand the determinants of IDU prevalence trends among Hispanics in these MSAs. Although the overall trend in Hispanic IDU prevalence was downward, prevalence increased in 17 MSAs when comparing early and late study years. It is also important to note that the total population of Hispanic IDUs in these MSAs increased in later study years, as can be seen in Figure 2. The study period corresponds with a substantial increase in the Hispanic population in the USA. Between 1990 and 2000, the US Hispanic population increased by 57.9%, representing almost 13 million new Hispanic residents.36 Hispanic immigration trends may have masked underlying trends in IDU prevalence among non-immigrant Hispanic populations. Our findings may actually conflate increases in non-immigrant (including Puerto Rican) Hispanic IDU prevalence offset by increases in Hispanic immigrant populations, who may be less likely to inject drugs.37,38

Results of the present study are consistent with results from our cross-sectional study that found little difference in IDU prevalence between Hispanic and non-Hispanic White MSA residents in 1998.39 Although the mean prevalence rates differ, as can be seen in Figure 1, the 1998 median prevalence rates among Hispanic (95 per 10,000) and non-Hispanic White (93 per 10,000)39 MSA residents are quite similar. IDU prevalence appears to have differed more greatly between Hispanic and non-Hispanic White MSA residents during earlier study years (1992–1997).

Limitations

The data were subject to several limitations. Injection drug use among Hispanics varies by national origin subgroup and immigrant or non-immigrant status, but only limited data on these characteristics were available. Hispanic immigrant IDUs, especially those with undocumented status, may avoid participating in the US Census, HIV testing, and/or utilizing drug treatment services.

CTS and TEDS data may underrepresent Hispanic IDUs because they may be less likely to utilize HIV testing and drug treatment services.6,7 This bias may be somewhat balanced by the likelihood that IAIDS data overrepresents Hispanics, as a result of their greater likelihood to progress to AIDS, once HIV-infected40; however, there are few data available to test this. CTS data represent only a small proportion of all HIV tests done in the USA and can include results for individuals tested more than once. Thus, they are an imperfect proxy for HIV prevalence among IDUs. In addition, changes in the completeness of reporting of CTS, TEDS, or IAIDS data over time may have biased the results.

While we adjusted IAIDS data for the proportions of IDUs who tested positive for HIV, we could not adjust for relative progression to AIDS or mortality, and those potential differences could have biased our IAIDS data. Further, average pseudo-likelihood HIV prevalence values were used in 22 MSAs where MSA-specific HIV test result values were missing. These values may not have represented the actual HIV prevalence well in some of those MSAs.

Conclusion

Estimates of IDU population prevalence among Hispanic residents of large MSAs showed a significant decline between 1992 and 2002; however, prevalence estimates increased in a substantial proportion of MSAs, and the proportion of IDUs that was Hispanic increased between 2002 and 2007 in almost half of the MSAs studied. These estimates can be used to study MSA-level policies and socioeconomic factors that may account for variations in trends across MSAs and across racial/ethnic groups and can be used to help guide prevention program planning for Hispanic IDUs within MSAs. Future research should also attempt to determine reasons for any differences in trends that might exist among Hispanic national origin subgroups and among immigrant and non-immigrant Hispanics.

Acknowledgments

This study was supported by a grant from the US National Institute on Drug Abuse (R01 DA018609). The authors would also like to acknowledge the NIH-funded Center for Drug Use and HIV Research (P30 DA121041) for its support and assistance.

Appendix

Table 5.

MSA-specific estimates of the number of Hispanic injection drug users and population prevalence rate of injection drug users among Hispanics (per 10,000 Hispanics aged 15–64), with 95 % confidence intervals, 1992–2002. N = the 96 most populated US metropolitan statistical areas

Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Akron, OH 1992 27 9 79 99 33 289
1993 24 8 72 84 28 251
1994 29 10 85 98 34 287
1995 26 9 78 84 29 251
1996 28 9 82 86 28 252
1997 29 10 85 86 30 252
1998 30 10 89 86 29 256
1999 37 12 108 102 33 297
2000 34 11 100 89 29 261
2001 41 14 122 102 35 302
2002 39 13 114 92 31 270
Albany–Schenectady–Troy, NY 1992 647 266 1,410 589 242 1,284
1993 576 238 1,252 502 207 1,091
1994 594 245 1,287 495 204 1,074
1995 551 228 1,190 440 182 951
1996 548 227 1,178 422 175 906
1997 536 223 1,147 395 164 846
1998 558 233 1,188 396 165 843
1999 538 225 1,140 368 154 779
2000 630 264 1,327 409 171 862
2001 572 241 1,197 356 150 745
2002 737 311 1,533 435 184 905
Albuquerque, NM 1992 5,093 2,788 7,412 333 182 484
1993 4,807 2,641 6,973 305 167 442
1994 5,121 2,824 7,401 312 172 451
1995 4,889 2,707 7,037 287 159 413
1996 4,864 2,706 6,971 276 153 395
1997 4,839 2,705 6,901 268 150 383
1998 4,877 2,742 6,919 264 148 374
1999 5,073 2,870 7,156 268 152 379
2000 4,988 2,840 6,996 256 146 359
2001 5,232 3,000 7,293 261 150 364
2002 5,185 2,993 7,182 251 145 348
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Allentown–Bethlehem–Easton, PA 1992 2,038 952 3,591 1,068 499 1,881
1993 1,879 880 3,300 924 433 1,622
1994 2,315 1,087 4,048 1,070 502 1,871
1995 2,088 984 3,635 905 426 1,575
1996 2,168 1,025 3,756 874 413 1,514
1997 2,224 1,056 3,832 840 399 1,447
1998 2,272 1,084 3,892 807 385 1,382
1999 2,744 1,316 4,671 915 439 1,558
2000 2,305 1,111 3,897 725 350 1,226
2001 2,886 1,399 4,844 865 419 1,451
2002 2,403 1,171 4,004 679 331 1,131
Ann Arbor, MI 1992 19 6 57 21 7 64
1993 19 6 55 21 7 61
1994 19 6 57 20 6 61
1995 20 7 59 20 7 60
1996 20 7 59 19 7 57
1997 21 7 62 19 6 57
1998 22 7 66 20 6 59
1999 23 8 67 20 7 57
2000 25 8 72 20 6 58
2001 26 9 76 20 7 59
2002 28 9 82 21 7 61
Atlanta, GA 1992 244 86 680 42 15 118
1993 229 81 638 34 12 96
1994 244 86 681 31 11 88
1995 228 81 636 25 9 68
1996 228 81 635 21 7 58
1997 228 81 634 17 6 48
1998 227 80 631 15 5 42
1999 240 85 668 14 5 38
2000 220 78 611 11 4 31
2001 236 84 655 11 4 30
2002 205 73 570 9 3 25
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Austin–San Marcos, TX 1992 3,708 1,611 7,330 278 121 550
1993 3,403 1,481 6,702 239 104 470
1994 4,068 1,775 7,982 267 117 525
1995 3,647 1,595 7,128 223 98 436
1996 3,639 1,596 7,079 209 92 406
1997 3,493 1,537 6,761 188 83 365
1998 3,341 1,476 6,430 169 75 325
1999 3,697 1,640 7,073 175 78 334
2000 3,111 1,386 5,912 136 61 259
2001 3,328 1,489 6,281 137 61 259
2002 2,710 1,218 5,080 107 48 201
Bakersfield, CA 1992 2,713 1,173 5,405 252 109 502
1993 2,543 1,102 5,048 225 97 447
1994 2,790 1,211 5,518 231 100 457
1995 2,641 1,150 5,203 211 92 416
1996 2,668 1,165 5,232 205 89 402
1997 2,738 1,199 5,341 200 88 391
1998 2,765 1,215 5,364 192 84 373
1999 3,099 1,368 5,977 204 90 393
2000 2,858 1,266 5,475 181 80 346
2001 3,186 1,418 6,063 193 86 368
2002 2,960 1,323 5,594 171 76 323
Baltimore, MD 1992 160 58 441 69 25 191
1993 195 70 539 80 29 221
1994 200 72 551 77 28 213
1995 227 82 627 84 30 232
1996 246 88 678 87 31 239
1997 266 96 734 88 32 244
1998 291 105 801 92 33 252
1999 327 118 901 97 35 268
2000 352 127 968 98 35 270
2001 396 143 1,089 104 37 285
2002 424 153 1,168 104 37 286
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Bergen–Passaic, NJ 1992 1,781 755 3,676 149 63 308
1993 1,785 758 3,671 143 61 293
1994 1,680 715 3,444 129 55 264
1995 1,654 706 3,376 121 52 248
1996 1,593 681 3,238 112 48 227
1997 1,554 667 3,143 104 45 210
1998 1,551 668 3,120 100 43 200
1999 1,586 685 3,173 98 42 197
2000 1,606 697 3,192 96 42 191
2001 1,586 691 3,133 91 40 181
2002 1,676 733 3,288 94 41 183
Birmingham, AL 1992 7 2 25 21 6 76
1993 6 2 22 16 5 58
1994 7 2 27 16 4 60
1995 6 2 23 11 4 44
1996 7 2 24 11 3 38
1997 7 2 24 9 3 32
1998 7 2 25 8 2 28
1999 9 3 32 9 3 30
2000 8 2 27 7 2 23
2001 10 3 34 8 2 27
2002 8 2 30 6 1 22
Boston, MA–NH 1992 4,260 1,733 9,552 250 102 560
1993 5,904 2,406 13,201 332 135 743
1994 4,797 1,957 10,693 260 106 579
1995 6,865 2,806 15,255 354 145 787
1996 7,398 3,030 16,378 365 149 807
1997 8,112 3,330 17,884 382 157 843
1998 8,798 3,621 19,306 395 163 867
1999 6,694 2,763 14,614 287 118 627
2000 10,207 4,227 22,161 419 174 911
2001 7,619 3,165 16,447 298 124 642
2002 11,791 4,912 25,310 443 184 950
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Lower limit
Buffalo–Niagara Falls, NY 1992 860 354 1,875 526 217 1,148
1993 1,037 428 2,253 610 252 1,326
1994 941 389 2,040 532 220 1,152
1995 1,096 454 2,365 600 249 1,295
1996 1,123 466 2,415 591 245 1,272
1997 1,137 473 2,434 584 243 1,250
1998 1,155 482 2,461 577 241 1,229
1999 1,035 433 2,193 504 211 1,068
2000 1,183 497 2,493 561 236 1,183
2001 1,038 438 2,174 480 203 1,005
2002 1,235 522 2,570 557 236 1,160
Charleston–North Charleston, SC 1992 32 10 97 55 17 167
1993 25 8 77 43 14 132
1994 28 9 86 47 15 146
1995 23 7 70 37 11 112
1996 22 7 67 34 11 103
1997 24 8 72 33 11 98
1998 25 8 77 31 10 95
1999 30 10 91 33 11 101
2000 27 9 83 28 9 87
2001 31 10 94 31 10 95
2002 29 9 88 28 9 86
Charlotte–Gastonia–Rock Hill, NC–SC 1992 49 17 146 44 15 131
1993 42 14 123 31 10 92
1994 49 16 144 29 10 86
1995 44 15 129 21 7 63
1996 45 15 131 17 6 51
1997 45 15 134 14 5 42
1998 46 16 136 12 4 34
1999 54 18 160 11 4 33
2000 49 17 144 9 3 25
2001 59 20 174 9 3 28
2002 51 17 149 8 3 22
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Chicago, IL 1992 4,103 1,628 9,696 66 26 157
1993 3,618 1,437 8,530 55 22 131
1994 4,184 1,664 9,839 61 24 143
1995 3,676 1,464 8,622 51 20 119
1996 3,715 1,482 8,685 48 19 113
1997 3,692 1,475 8,601 46 18 106
1998 3,813 1,527 8,847 45 18 103
1999 4,558 1,830 10,527 51 20 117
2000 4,000 1,610 9,195 42 17 97
2001 4,958 2,001 11,343 51 20 116
2002 4,372 1,768 9,952 43 18 99
Cincinnati, OH–KY–IN 1992 79 26 233 128 42 377
1993 66 22 195 98 33 290
1994 78 26 229 108 36 317
1995 65 22 192 84 28 248
1996 65 22 191 77 26 227
1997 66 22 193 73 24 212
1998 68 23 200 68 23 201
1999 85 29 251 79 27 232
2000 76 26 224 63 21 185
2001 96 32 281 73 24 215
2002 85 28 249 61 20 179
Cleveland–Lorain–Elyria, OH 1992 1,421 565 3,327 410 163 961
1993 1,251 498 2,922 345 137 805
1994 1,447 577 3,371 385 153 897
1995 1,294 517 3,005 330 132 766
1996 1,318 528 3,053 323 129 747
1997 1,342 538 3,096 318 128 734
1998 1,368 550 3,143 313 126 719
1999 1,570 632 3,590 347 140 794
2000 1,467 593 3,339 311 126 708
2001 1,672 677 3,786 343 139 776
2002 1,572 638 3,543 313 127 705
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Columbus, OH 1992 120 42 339 126 44 356
1993 111 39 313 105 37 297
1994 131 46 369 115 40 323
1995 119 42 335 95 33 267
1996 123 43 344 89 31 250
1997 127 44 355 84 29 236
1998 133 47 373 81 28 226
1999 159 56 446 88 31 246
2000 149 52 416 74 26 208
2001 182 64 509 83 29 232
2002 173 60 482 74 26 206
Dallas, TX 1992 1,868 720 4,709 64 25 161
1993 1,596 616 4,016 50 19 127
1994 2,014 777 5,056 59 23 148
1995 1,815 701 4,549 49 19 123
1996 1,919 742 4,797 48 18 119
1997 2,060 798 5,136 47 18 118
1998 2,213 858 5,498 47 18 116
1999 2,769 1,076 6,857 54 21 134
2000 2,523 982 6,226 46 18 114
2001 3,278 1,278 8,059 56 22 138
2002 2,882 1,125 7,060 47 18 114
Dayton–Springfield, OH 1992 12 4 39 23 8 73
1993 11 3 34 20 5 61
1994 12 4 37 21 7 64
1995 10 3 32 17 5 53
1996 10 3 32 16 5 51
1997 10 3 32 15 5 49
1998 11 3 34 16 4 50
1999 13 4 40 18 6 56
2000 13 4 41 17 5 54
2001 16 5 49 20 6 62
2002 16 5 50 19 6 60
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Denver, CO 1992 5,008 2,166 9,975 318 137 633
1993 4,556 1,975 9,043 268 116 532
1994 4,853 2,108 9,598 269 117 532
1995 4,934 2,149 9,718 256 112 504
1996 5,172 2,259 10,141 251 110 492
1997 5,429 2,378 10,591 247 108 481
1998 5,681 2,498 11,021 243 107 472
1999 4,547 2,007 8,767 182 80 351
2000 5,717 2,535 10,952 216 96 414
2001 4,504 2,006 8,571 161 72 307
2002 5,666 2,534 10,706 195 87 368
Detroit, MI 1992 403 149 1,124 69 25 191
1993 425 158 1,183 70 26 194
1994 418 155 1,162 66 25 184
1995 465 172 1,292 70 26 195
1996 493 183 1,370 70 26 195
1997 515 191 1,429 70 26 195
1998 532 198 1,474 70 26 193
1999 469 175 1,299 59 22 164
2000 555 206 1,533 67 25 185
2001 481 179 1,329 55 21 153
2002 586 218 1,616 65 24 179
El Paso, TX 1992 10,476 7,374 12,461 372 262 443
1993 8,651 6,110 10,270 297 210 352
1994 9,862 6,989 11,682 328 232 388
1995 8,004 5,694 9,457 260 185 307
1996 7,564 5,404 8,914 242 173 285
1997 7,363 5,285 8,653 230 165 271
1998 6,930 4,999 8,119 213 153 249
1999 7,397 5,365 8,638 224 162 261
2000 6,104 4,452 7,104 181 132 211
2001 5,966 4,378 6,920 175 128 203
2002 5,243 3,870 6,059 152 112 176
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Fort Lauderdale, FL 1992 686 264 1,722 74 29 186
1993 574 221 1,437 56 22 140
1994 697 269 1,744 62 24 155
1995 585 226 1,460 47 18 118
1996 597 231 1,487 44 17 109
1997 615 238 1,526 41 16 102
1998 631 245 1,562 39 15 96
1999 769 299 1,897 43 17 107
2000 663 258 1,628 34 13 84
2001 814 317 1,992 39 15 95
2002 692 270 1,688 31 12 74
Fort Worth–Arlington, TX 1992 1,957 760 4,850 170 66 422
1993 1,647 640 4,073 134 52 332
1994 2,006 781 4,951 152 59 376
1995 1,732 675 4,266 122 48 301
1996 1,774 692 4,358 116 45 285
1997 1,820 711 4,457 110 43 270
1998 1,859 727 4,538 105 41 255
1999 2,242 879 5,452 117 46 284
2000 1,955 768 4,734 95 37 229
2001 2,342 922 5,649 106 42 256
2002 2,047 807 4,918 87 34 210
Fresno, CA 1992 5,130 2,622 8,057 278 142 436
1993 7,532 3,863 11,789 388 199 607
1994 5,865 3,018 9,143 289 149 451
1995 7,590 3,921 11,782 361 187 561
1996 7,784 4,038 12,024 354 184 547
1997 8,087 4,216 12,427 353 184 542
1998 8,430 4,419 12,881 354 186 541
1999 9,116 4,807 13,846 369 194 560
2000 8,857 4,700 13,366 345 183 521
2001 9,787 5,226 14,669 370 198 555
2002 9,010 4,843 13,412 329 177 489
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Gary, IN 1992 304 110 777 95 34 242
1993 262 95 669 79 29 203
1994 327 119 833 97 35 246
1995 312 114 794 89 32 226
1996 336 123 854 92 34 233
1997 361 132 915 95 35 241
1998 384 140 971 97 35 245
1999 387 142 975 95 35 239
2000 407 149 1,023 97 35 243
2001 419 154 1,049 97 36 244
2002 439 161 1,096 100 37 250
Grand Rapids–Muskegon–Holland, MI 1992 205 76 513 96 35 240
1993 173 64 433 75 28 187
1994 200 75 500 79 30 198
1995 180 67 451 65 24 162
1996 183 68 456 59 22 148
1997 185 69 460 55 20 136
1998 197 74 488 53 20 132
1999 215 81 532 53 20 131
2000 218 82 539 50 19 122
2001 234 88 575 50 19 123
2002 243 91 596 50 19 122
Greensboro–Winston–Salem–High Point, NC 1992 50 17 152 62 21 190
1993 41 13 123 42 13 126
1994 49 16 147 40 13 119
1995 40 13 121 26 8 78
1996 40 13 120 21 7 62
1997 41 13 122 17 5 50
1998 42 14 125 14 5 41
1999 53 17 158 14 5 43
2000 43 14 128 10 3 29
2001 53 17 158 11 4 33
2002 43 14 129 8 3 25
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Greenville–Spartanburg–Anderson, SC 1992 30 9 91 54 16 164
1993 23 7 72 36 11 113
1994 28 9 87 39 13 122
1995 24 8 73 28 9 86
1996 24 8 74 24 8 75
1997 25 8 77 21 7 65
1998 26 8 80 18 6 57
1999 30 10 94 18 6 56
2000 29 9 91 15 5 47
2001 35 11 106 17 5 50
2002 33 11 103 15 5 45
Harrisburg–Lebanon–Carlisle, PA 1992 481 193 1,100 656 263 1,501
1993 451 181 1,028 577 232 1,316
1994 568 225 1,260 685 271 1,519
1995 532 211 1,179 603 239 1,337
1996 604 239 1,333 631 250 1,393
1997 713 283 1,569 698 277 1,537
1998 819 326 1,794 749 298 1,641
1999 1,031 412 2,248 887 355 1,935
2000 836 335 1,813 678 272 1,470
2001 923 370 1,991 717 288 1,547
2002 761 306 1,633 561 226 1,205
Hartford, CT 1992 5,073 2,588 7,978 968 494 1,523
1993 5,043 2,581 7,903 931 476 1,458
1994 5,201 2,671 8,117 927 476 1,447
1995 5,126 2,643 7,966 894 461 1,389
1996 5,154 2,669 7,972 861 446 1,332
1997 5,128 2,668 7,890 824 429 1,268
1998 5,070 2,652 7,757 790 413 1,209
1999 4,990 2,626 7,589 749 394 1,140
2000 5,002 2,648 7,557 719 381 1,087
2001 4,953 2,639 7,433 688 367 1,032
2002 5,028 2,696 7,493 675 362 1,006
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Honolulu, HI 1992 253 92 660 68 25 177
1993 242 88 628 65 24 168
1994 279 101 726 75 27 195
1995 256 93 664 69 25 180
1996 261 95 675 70 26 181
1997 270 98 699 71 26 185
1998 281 102 724 74 27 192
1999 351 128 903 96 35 246
2000 294 108 756 80 30 207
2001 385 141 986 101 37 259
2002 318 116 811 80 29 205
Houston, TX 1992 8,186 3,323 18,410 154 62 345
1993 6,399 2,602 14,352 113 46 255
1994 8,057 3,281 18,017 135 55 303
1995 6,339 2,586 14,129 101 41 225
1996 6,330 2,587 14,057 95 39 212
1997 6,386 2,615 14,122 91 37 201
1998 6,329 2,599 13,932 85 35 187
1999 7,807 3,215 17,098 99 41 216
2000 6,172 2,550 13,444 74 31 161
2001 7,533 3,122 16,316 86 36 186
2002 5,936 2,467 12,785 64 27 139
Indianapolis, IN 1992 134 46 382 132 45 376
1993 126 43 358 109 37 310
1994 134 46 381 102 35 291
1995 121 42 344 80 28 228
1996 117 40 334 67 23 191
1997 115 40 327 57 20 162
1998 117 40 333 50 17 143
1999 140 48 398 52 18 148
2000 130 45 370 43 15 122
2001 157 54 445 47 16 134
2002 149 51 421 42 14 118
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Jacksonville, FL 1992 237 85 642 138 49 373
1993 177 63 479 98 35 266
1994 223 80 604 117 42 318
1995 177 64 479 87 32 236
1996 182 65 492 81 29 220
1997 187 67 506 78 28 210
1998 195 70 527 77 28 208
1999 241 87 651 90 33 244
2000 212 76 571 74 26 199
2001 267 96 719 85 31 230
2002 234 84 629 69 25 185
Jersey City, NJ 1992 2,677 1,208 4,969 193 87 359
1993 2,185 988 4,040 154 70 284
1994 2,377 1,078 4,379 163 74 301
1995 1,935 880 3,548 129 59 237
1996 1,806 824 3,296 117 53 213
1997 1,674 767 3,040 105 48 191
1998 1,617 744 2,919 99 45 178
1999 1,807 835 3,242 108 50 194
2000 1,758 817 3,132 103 48 184
2001 1,943 907 3,438 113 53 201
2002 1,983 930 3,483 116 54 203
Kansas City, MO–KS 1992 203 73 553 61 22 166
1993 185 66 502 52 18 141
1994 209 75 568 54 20 148
1995 187 67 509 45 16 123
1996 191 68 518 43 15 116
1997 195 70 528 40 14 108
1998 192 69 520 36 13 99
1999 209 75 565 37 13 99
2000 184 66 497 30 11 81
2001 199 72 537 31 11 82
2002 175 63 472 25 9 69
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Knoxville, TN 1992 13 3 45 53 12 183
1993 12 3 42 45 11 156
1994 14 4 50 46 13 166
1995 13 4 45 39 12 134
1996 13 4 48 34 11 127
1997 14 4 50 34 10 120
1998 14 4 50 30 9 108
1999 17 5 60 33 10 117
2000 15 4 52 25 7 88
2001 17 5 61 27 8 96
2002 15 4 54 22 6 78
Las Vegas, NV–AZ 1992 1,046 403 2,634 136 52 342
1993 885 341 2,222 103 40 259
1994 1,138 440 2,853 115 44 288
1995 1,010 391 2,528 88 34 221
1996 1,069 414 2,668 83 32 206
1997 1,152 447 2,869 77 30 191
1998 1,197 465 2,971 70 27 174
1999 1,374 534 3,398 72 28 178
2000 1,244 485 3,066 59 23 145
2001 1,394 544 3,423 61 24 149
2002 1,245 487 3,045 51 20 125
Little Rock–North Little Rock, AR 1992 20 6 61 61 18 188
1993 17 5 53 46 14 144
1994 20 6 61 48 14 147
1995 18 6 55 37 12 114
1996 18 6 56 31 10 96
1997 19 6 58 30 9 91
1998 19 6 60 27 9 85
1999 21 7 65 27 9 83
2000 19 6 61 22 7 71
2001 21 7 67 23 8 74
2002 19 6 60 20 6 62
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Los Angeles–Long Beach, CA 1992 35,172 16,887 59,778 153 73 259
1993 38,308 18,448 64,866 163 79 276
1994 34,217 16,529 57,707 144 69 242
1995 37,321 18,090 62,662 155 75 260
1996 37,129 18,066 62,036 151 74 253
1997 37,625 18,388 62,526 149 73 248
1998 38,317 18,818 63,302 147 72 243
1999 37,282 18,409 61,201 139 69 228
2000 39,701 19,717 64,732 144 72 235
2001 40,338 20,153 65,309 143 71 232
2002 41,086 20,645 66,039 143 72 229
Louisville, KY–IN 1992 49 12 194 109 27 430
1993 43 11 171 84 22 335
1994 60 15 237 107 27 423
1995 53 13 210 85 21 338
1996 58 15 228 83 21 326
1997 62 16 244 79 20 309
1998 66 16 257 73 18 285
1999 78 20 306 76 19 296
2000 71 18 279 61 15 239
2001 88 22 344 70 17 273
2002 79 20 309 59 15 231
Memphis, TN–AR–MS 1992 38 12 125 55 17 181
1993 39 12 127 50 16 164
1994 39 12 127 44 14 144
1995 37 11 122 36 11 120
1996 37 11 120 31 9 102
1997 37 11 122 28 8 91
1998 39 12 129 25 8 83
1999 50 15 163 28 9 93
2000 47 14 152 24 7 76
2001 58 17 189 28 8 90
2002 55 16 178 25 7 81
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Miami, FL 1992 5,238 2,309 10,089 75 33 145
1993 3,823 1,689 7,338 54 24 104
1994 4,429 1,962 8,468 61 27 117
1995 3,337 1,482 6,354 44 20 84
1996 3,160 1,408 5,988 40 18 76
1997 2,943 1,315 5,548 36 16 69
1998 2,906 1,304 5,447 35 16 66
1999 3,396 1,530 6,326 40 18 74
2000 2,831 1,282 5,239 32 14 59
2001 3,265 1,485 6,000 36 16 66
2002 2,817 1,287 5,139 31 14 56
Middlesex–Somerset–Hunterdon, NJ 1992 843 342 1,894 145 59 325
1993 837 340 1,875 135 55 302
1994 799 325 1,784 121 49 271
1995 795 324 1,769 114 46 253
1996 782 319 1,734 105 43 233
1997 772 316 1,705 97 40 215
1998 785 322 1,726 94 38 206
1999 800 329 1,749 91 37 198
2000 829 342 1,804 89 37 194
2001 847 351 1,832 87 36 187
2002 880 365 1,892 86 36 185
Milwaukee–Waukesha, WI 1992 608 233 1,428 172 66 403
1993 526 202 1,234 139 53 326
1994 641 246 1,500 157 60 368
1995 569 218 1,328 129 50 302
1996 593 228 1,381 126 48 294
1997 616 237 1,430 123 47 285
1998 653 252 1,510 122 47 282
1999 728 282 1,678 128 50 295
2000 690 267 1,582 114 44 262
2001 788 306 1,800 124 48 284
2002 735 286 1,670 110 43 251
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Minneapolis–St. Paul, MN–WI 1992 276 100 739 97 35 260
1993 230 84 615 73 27 195
1994 274 99 732 80 29 213
1995 230 84 615 60 22 161
1996 233 85 622 54 20 145
1997 248 90 660 51 19 137
1998 263 95 699 49 18 129
1999 336 122 893 56 20 148
2000 300 109 794 45 17 120
2001 396 144 1,049 56 20 149
2002 349 127 922 47 17 124
Monmouth–Ocean, NJ 1992 376 143 979 137 52 357
1993 324 123 843 111 42 289
1994 347 132 900 112 43 292
1995 320 122 830 97 37 253
1996 319 121 825 91 35 236
1997 323 123 833 87 33 224
1998 339 130 873 86 33 222
1999 322 123 827 78 30 200
2000 372 142 952 85 32 218
2001 327 125 835 70 27 180
2002 414 159 1,052 84 32 213
Nashville, TN 1992 61 20 185 86 28 262
1993 59 19 178 71 23 215
1994 77 25 233 77 25 233
1995 72 24 218 59 20 179
1996 80 26 241 54 18 163
1997 86 28 260 49 16 147
1998 91 30 274 43 14 128
1999 109 36 328 43 14 130
2000 97 32 292 33 11 99
2001 115 37 345 36 11 107
2002 105 34 315 31 10 92
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Nassau–Suffolk, NY 1992 909 355 2,225 69 27 168
1993 903 353 2,206 64 25 157
1994 897 351 2,186 61 24 148
1995 960 376 2,334 62 24 151
1996 993 390 2,410 61 24 148
1997 1,050 413 2,539 61 24 149
1998 1,115 439 2,688 62 24 150
1999 929 367 2,230 49 19 118
2000 1,222 483 2,920 62 24 148
2001 955 379 2,273 46 18 110
2002 1,336 530 3,166 62 24 146
New Haven–Meriden, CT 1992 4,887 2,208 9,054 551 249 1,021
1993 4,567 2,069 8,430 493 223 910
1994 4,768 2,166 8,767 494 224 908
1995 4,668 2,126 8,545 463 211 848
1996 4,722 2,157 8,602 445 203 810
1997 4,790 2,197 8,681 430 197 779
1998 4,788 2,206 8,627 413 190 744
1999 4,614 2,135 8,260 381 176 683
2000 4,698 2,185 8,355 371 173 661
2001 4,541 2,123 8,017 345 161 609
2002 4,604 2,163 8,071 335 157 588
New Orleans, LA 1992 240 85 666 63 22 176
1993 198 70 549 52 18 145
1994 252 89 698 66 23 182
1995 209 74 579 54 19 148
1996 214 76 592 55 19 151
1997 221 78 610 56 20 154
1998 228 81 630 57 20 158
1999 289 103 798 72 26 199
2000 242 86 668 60 21 165
2001 307 109 845 74 26 203
2002 259 92 713 60 21 166
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
New York, NY 1992 40,762 19,585 69,210 304 146 517
1993 41,256 19,882 69,788 300 145 508
1994 38,852 18,782 65,458 276 134 466
1995 39,547 19,183 66,334 276 134 462
1996 38,804 18,895 64,770 265 129 442
1997 38,131 18,649 63,304 254 124 422
1998 38,016 18,685 62,743 247 122 408
1999 35,515 17,550 58,243 227 112 372
2000 38,162 18,968 62,161 239 119 389
2001 34,699 17,349 56,122 214 107 346
2002 38,136 19,179 61,237 233 117 374
Newark, NJ 1992 4,137 1,722 8,853 288 120 617
1993 3,583 1,494 7,643 240 100 511
1994 3,850 1,608 8,186 249 104 529
1995 3,406 1,425 7,216 212 89 450
1996 3,353 1,406 7,075 201 84 424
1997 3,309 1,391 6,949 191 80 400
1998 3,318 1,399 6,932 184 78 384
1999 3,351 1,418 6,962 180 76 374
2000 3,359 1,427 6,937 175 74 361
2001 3,231 1,378 6,632 162 69 332
2002 3,452 1,477 7,041 167 71 340
Norfolk–Virginia Beach–Newport News, VA–NC 1992 116 41 324 49 17 137
1993 116 41 324 47 17 132
1994 138 48 385 55 19 154
1995 130 46 363 50 18 139
1996 138 48 385 50 17 140
1997 146 51 408 51 18 142
1998 151 53 420 51 18 141
1999 183 64 509 59 20 163
2000 165 58 459 50 17 138
2001 195 69 543 56 20 157
2002 179 63 498 49 17 136
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Oakland, CA 1992 3,542 1,444 7,904 173 71 387
1993 4,088 1,669 9,094 192 78 427
1994 3,468 1,418 7,693 157 64 348
1995 3,995 1,637 8,833 174 71 385
1996 4,004 1,643 8,819 167 69 368
1997 4,099 1,686 8,990 162 67 356
1998 4,160 1,716 9,081 156 64 341
1999 3,931 1,627 8,538 141 58 305
2000 4,152 1,724 8,968 142 59 306
2001 4,042 1,683 8,680 132 55 283
2002 4,006 1,673 8,553 127 53 271
Oklahoma City, OK 1992 131 47 358 53 19 145
1993 144 52 394 54 19 148
1994 127 46 348 44 16 121
1995 134 48 365 43 15 117
1996 128 46 350 38 14 103
1997 126 45 343 34 12 93
1998 127 46 346 31 11 86
1999 131 47 356 29 11 80
2000 136 49 369 29 10 78
2001 143 51 388 28 10 77
2002 147 53 398 27 10 74
Omaha, NE–IA 1992 82 29 221 65 23 175
1993 88 32 237 63 23 171
1994 88 31 235 57 20 153
1995 91 32 243 53 19 142
1996 93 33 248 49 17 131
1997 92 33 247 45 16 120
1998 97 35 260 43 16 116
1999 113 41 302 47 17 124
2000 116 42 308 45 16 118
2001 134 48 356 48 17 128
2002 137 49 364 47 17 124
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Orange County, CA 1992 8,395 4,004 14,394 202 96 347
1993 9,012 4,311 15,395 209 100 357
1994 7,641 3,666 13,000 171 82 290
1995 8,176 3,936 13,848 176 85 299
1996 7,962 3,848 13,421 166 80 279
1997 8,012 3,889 13,432 159 77 266
1998 8,130 3,965 13,549 153 75 256
1999 7,357 3,607 12,183 134 66 222
2000 7,969 3,930 13,108 140 69 230
2001 6,797 3,371 11,100 116 58 189
2002 7,726 3,854 12,527 129 64 209
Orlando, FL 1992 1,631 708 3,225 191 83 379
1993 1,515 659 2,986 161 70 317
1994 1,865 813 3,661 180 79 354
1995 1,704 744 3,331 149 65 292
1996 1,828 801 3,558 144 63 281
1997 1,978 870 3,831 141 62 273
1998 2,136 942 4,113 139 61 267
1999 2,747 1,217 5,257 162 72 310
2000 2,565 1,141 4,877 137 61 261
2001 3,220 1,439 6,081 159 71 301
2002 3,058 1,373 5,735 141 63 264
Philadelphia, PA–NJ 1992 5,583 2,220 13,153 453 180 1,066
1993 5,432 2,162 12,766 423 168 995
1994 6,094 2,429 14,284 457 182 1,070
1995 5,818 2,322 13,600 419 167 979
1996 5,973 2,387 13,916 411 164 958
1997 6,098 2,442 14,157 403 161 935
1998 6,332 2,542 14,641 402 161 929
1999 7,353 2,958 16,924 451 181 1,038
2000 7,046 2,843 16,141 417 168 954
2001 8,447 3,417 19,253 482 195 1,098
2002 8,091 3,280 18,352 444 180 1,008
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Phoenix–Mesa, AZ 1992 3,387 1,415 7,153 122 51 257
1993 3,398 1,423 7,155 112 47 236
1994 3,640 1,527 7,638 109 46 230
1995 3,668 1,542 7,667 101 42 211
1996 3,769 1,588 7,846 95 40 199
1997 3,928 1,660 8,139 92 39 190
1998 4,266 1,808 8,793 93 39 191
1999 5,023 2,136 10,295 102 43 209
2000 5,100 2,177 10,390 97 41 197
2001 6,270 2,687 12,693 112 48 226
2002 6,256 2,690 12,583 105 45 211
Pittsburgh, PA 1992 101 35 288 110 38 313
1993 94 32 268 100 34 285
1994 110 38 315 114 40 328
1995 102 35 291 104 36 297
1996 106 37 304 105 37 300
1997 110 38 313 106 37 303
1998 116 40 332 110 38 314
1999 138 48 395 128 44 365
2000 133 46 378 117 40 331
2001 153 53 435 126 44 357
2002 154 54 440 119 42 340
Portland–Vancouver, OR–WA 1992 784 295 2,100 189 71 506
1993 875 330 2,342 188 71 504
1994 786 297 2,101 152 57 405
1995 913 345 2,438 157 59 418
1996 942 356 2,511 146 55 388
1997 978 370 2,602 135 51 360
1998 1,026 388 2,726 129 49 343
1999 929 352 2,461 106 40 281
2000 1,111 422 2,938 117 45 310
2001 1,054 400 2,779 104 39 273
2002 1,222 464 3,215 113 43 298
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Providence–Fall River–Warwick, RI–MA 1992 449 175 1,102 134 52 330
1993 529 207 1,297 148 58 363
1994 428 167 1,047 112 44 275
1995 597 234 1,458 147 57 358
1996 634 248 1,544 146 57 355
1997 674 264 1,636 145 57 351
1998 720 283 1,742 145 57 350
1999 418 165 1,007 79 31 189
2000 772 304 1,851 136 54 326
2001 453 179 1,083 75 30 180
2002 848 336 2,018 133 53 317
Raleigh–Durham–Chapel Hill, NC 1992 69 24 201 60 21 174
1993 57 20 166 41 14 120
1994 70 24 201 41 14 117
1995 59 20 170 28 10 81
1996 60 20 172 23 8 66
1997 60 21 174 19 7 54
1998 61 21 176 16 5 45
1999 71 24 205 15 5 44
2000 60 20 172 11 4 31
2001 71 24 206 12 4 35
2002 59 20 169 9 3 27
Richmond–Petersburg, VA 1992 86 28 260 114 37 345
1993 73 24 221 89 29 268
1994 89 29 267 98 32 295
1995 76 25 230 77 25 232
1996 78 26 235 71 24 214
1997 81 26 243 67 21 200
1998 83 27 249 61 20 184
1999 93 31 280 62 21 187
2000 86 28 259 51 17 154
2001 95 31 285 52 17 155
2002 90 29 269 45 14 134
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Riverside–San Bernardino, CA 1992 10,684 5,099 18,297 213 102 365
1993 11,645 5,575 19,869 221 106 376
1994 9,310 4,470 15,821 168 81 285
1995 10,404 5,013 17,603 179 86 302
1996 10,103 4,886 17,010 166 80 279
1997 10,266 4,986 17,190 160 78 267
1998 10,271 5,013 17,098 151 74 251
1999 9,366 4,596 15,492 130 64 214
2000 9,582 4,729 15,742 125 62 206
2001 8,768 4,352 14,303 108 54 176
2002 8,407 4,197 13,615 97 49 158
Rochester, NY 1992 1,165 494 2,396 524 222 1,077
1993 1,061 451 2,175 456 194 934
1994 1,196 510 2,443 494 211 1,008
1995 1,102 470 2,241 439 187 894
1996 1,105 473 2,237 424 182 859
1997 1,110 476 2,236 411 176 828
1998 1,133 488 2,272 405 175 813
1999 1,240 536 2,472 431 186 860
2000 1,270 551 2,515 422 183 836
2001 1,430 624 2,814 467 204 918
2002 1,494 654 2,920 476 208 930
Sacramento, CA 1992 2,625 1,066 5,896 243 99 547
1993 2,792 1,136 6,254 249 101 559
1994 2,479 1,010 5,536 214 87 478
1995 2,688 1,097 5,984 224 92 499
1996 2,710 1,108 6,010 217 89 482
1997 2,802 1,148 6,189 215 88 476
1998 2,862 1,176 6,291 210 86 462
1999 2,741 1,129 5,995 193 79 421
2000 2,764 1,143 6,012 185 77 403
2001 2,709 1,124 5,860 169 70 366
2002 2,603 1,082 5,599 152 63 327
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
St. Louis, MO–IL 1992 102 35 294 56 19 161
1993 82 28 236 43 15 124
1994 96 33 276 48 17 139
1995 78 27 226 38 13 109
1996 77 26 221 36 12 102
1997 76 26 220 33 11 96
1998 78 27 226 33 11 95
1999 92 32 266 37 13 106
2000 82 28 237 31 11 90
2001 100 34 287 36 12 102
2002 89 31 257 30 10 86
Salt Lake City–Ogden, UT 1992 470 183 1,149 103 40 252
1993 681 266 1,661 135 53 330
1994 608 238 1,482 109 43 267
1995 896 351 2,178 147 58 358
1996 1,010 396 2,447 149 58 361
1997 1,105 434 2,670 146 57 353
1998 1,129 444 2,718 137 54 329
1999 1,018 402 2,441 115 45 275
2000 1,168 462 2,788 125 49 297
2001 1,189 471 2,827 120 48 285
2002 1,193 474 2,825 115 46 272
San Antonio, TX 1992 12,889 7,401 17,937 306 175 425
1993 11,253 6,485 15,611 259 149 359
1994 11,822 6,839 16,344 263 152 364
1995 10,370 6,025 14,282 223 130 308
1996 9,892 5,774 13,568 207 121 284
1997 9,460 5,551 12,917 193 113 263
1998 9,488 5,599 12,893 188 111 256
1999 9,758 5,795 13,191 189 112 255
2000 9,213 5,508 12,386 173 103 232
2001 9,506 5,722 12,706 174 105 232
2002 9,079 5,503 12,065 161 98 214
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
San Diego, CA 1992 6,729 3,000 12,749 185 82 350
1993 7,761 3,469 14,653 207 92 390
1994 7,085 3,175 13,324 183 82 344
1995 7,805 3,507 14,617 196 88 367
1996 7,879 3,551 14,685 191 86 357
1997 8,099 3,663 15,015 189 85 350
1998 8,152 3,702 15,025 182 83 335
1999 8,224 3,752 15,063 176 80 322
2000 8,258 3,786 15,024 170 78 309
2001 8,279 3,814 14,958 165 76 298
2002 8,226 3,808 14,756 158 73 284
San Francisco, CA 1992 3,491 1,393 8,158 207 82 483
1993 3,874 1,548 9,030 224 89 522
1994 3,499 1,400 8,133 198 79 460
1995 3,943 1,579 9,140 219 88 507
1996 4,002 1,606 9,246 216 87 500
1997 4,112 1,653 9,464 215 86 495
1998 4,163 1,677 9,543 211 85 485
1999 3,910 1,580 8,921 195 79 444
2000 4,210 1,706 9,559 205 83 465
2001 4,106 1,668 9,276 199 81 450
2002 4,100 1,669 9,215 200 81 448
San Jose, CA 1992 4,557 2,047 8,513 207 93 387
1993 3,977 1,791 7,402 176 79 328
1994 3,968 1,792 7,358 172 78 319
1995 3,413 1,546 6,301 144 65 267
1996 3,153 1,433 5,793 129 59 238
1997 2,966 1,352 5,420 118 54 215
1998 2,822 1,292 5,128 109 50 198
1999 2,973 1,368 5,368 112 52 203
2000 2,539 1,174 4,554 94 43 168
2001 2,586 1,202 4,605 96 44 170
2002 2,145 1,002 3,793 80 37 141
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
San Juan-Bayamon, PR (note: Data are from Brady et al.8 Confidence intervals are not available; however, lower and upper values for the range of estimates for population prevalence rates are presented in lower and upper limit columns) 1992 17,484 146 118 187
1993 15,106 125 68 180
1994 17,194 141 120 173
1995 15,626 127 94 166
1996 16,013 129 107 160
1997 16,405 131 120 154
1998 16,548 131 120 148
1999 16,182 127 114 142
2000 15,935 124 108 131
2001 15,034 116 102 131
2002 15,031 115 95 128
Sarasota–Bradenton, FL 1992 111 40 292 93 33 244
1993 105 38 278 80 29 211
1994 129 47 341 90 33 237
1995 123 45 325 77 28 204
1996 133 48 350 76 27 199
1997 144 52 380 75 27 197
1998 157 57 413 74 27 195
1999 200 72 523 86 31 224
2000 190 69 498 74 27 193
2001 242 88 631 86 31 224
2002 229 83 595 75 27 196
Scranton–Wilkes-Barre–Hazleton, PA 1992 23 8 67 84 29 244
1993 24 8 68 82 27 231
1994 24 8 68 78 26 220
1995 25 9 73 75 27 219
1996 27 9 77 75 25 213
1997 28 10 80 72 26 206
1998 29 10 82 70 24 197
1999 25 9 71 56 20 159
2000 32 11 91 65 22 185
2001 28 10 81 52 19 150
2002 36 13 104 61 22 176
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Seattle–Bellevue–Everett, WA 1992 825 310 2,219 181 68 487
1993 1,079 406 2,897 218 82 585
1994 947 356 2,540 177 67 476
1995 1,137 428 3,046 196 74 525
1996 1,161 437 3,105 183 69 491
1997 1,185 447 3,166 169 64 453
1998 1,212 457 3,232 159 60 425
1999 1,134 428 3,017 139 52 369
2000 1,234 467 3,275 141 53 375
2001 1,162 440 3,076 125 47 330
2002 1,267 480 3,350 130 49 344
Springfield, MA 1992 2,124 1,033 3,542 661 321 1,102
1993 2,347 1,145 3,900 700 341 1,163
1994 2,294 1,123 3,796 658 322 1,089
1995 2,676 1,315 4,409 735 361 1,212
1996 2,863 1,412 4,695 753 371 1,235
1997 3,075 1,524 5,015 771 382 1,257
1998 3,293 1,640 5,339 786 392 1,275
1999 2,833 1,419 4,565 646 324 1,041
2000 3,607 1,817 5,773 787 396 1,260
2001 3,127 1,585 4,970 659 334 1,048
2002 4,001 2,040 6,312 809 413 1,277
Stockton–Lodi, CA 1992 1,771 771 3,489 227 99 448
1993 1,757 766 3,449 217 95 426
1994 1,830 800 3,578 218 95 426
1995 1,975 865 3,847 227 100 443
1996 2,093 920 4,058 232 102 450
1997 2,250 992 4,339 239 105 461
1998 2,378 1,052 4,561 242 107 465
1999 2,449 1,088 4,667 238 106 453
2000 2,679 1,196 5,073 247 110 467
2001 2,998 1,344 5,639 257 115 483
2002 3,117 1,403 5,821 250 113 468
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Syracuse, NY 1992 335 128 785 463 177 1,085
1993 280 108 657 371 143 870
1994 314 121 734 406 156 948
1995 269 103 627 339 130 789
1996 261 101 607 314 121 729
1997 259 100 601 303 117 704
1998 253 98 584 287 111 662
1999 276 107 634 305 118 700
2000 259 100 593 274 106 626
2001 286 111 651 289 112 657
2002 271 106 615 264 103 599
Tacoma, WA 1992 292 111 768 194 74 509
1993 404 153 1,059 252 95 660
1994 314 119 823 184 70 481
1995 406 151 1,031 223 83 566
1996 407 152 1,032 210 78 532
1997 412 154 1,043 199 75 505
1998 428 160 1,081 194 73 490
1999 424 158 1,068 181 67 455
2000 460 172 1,157 186 70 469
2001 483 181 1,210 184 69 460
2002 499 187 1,248 179 67 447
Tampa–St. Petersburg–Clearwater, FL 1992 1,073 412 2,726 105 40 268
1993 878 338 2,227 81 31 206
1994 1,100 423 2,786 97 37 245
1995 934 360 2,361 77 30 195
1996 967 373 2,438 75 29 189
1997 1,031 398 2,592 75 29 189
1998 1,099 425 2,757 76 29 190
1999 1,377 533 3,441 89 34 222
2000 1,236 479 3,078 75 29 186
2001 1,528 594 3,792 87 34 215
2002 1,383 538 3,421 73 29 181
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Toledo, OH 1992 170 63 429 131 48 329
1993 148 55 373 110 41 277
1994 177 66 446 128 48 323
1995 153 57 385 107 40 270
1996 156 58 392 106 39 266
1997 163 60 407 108 40 269
1998 178 66 445 114 42 286
1999 210 78 521 132 49 327
2000 209 78 517 127 47 313
2001 254 95 627 150 56 370
2002 252 94 620 144 54 355
Tucson, AZ 1992 2,940 1,327 5,444 260 117 482
1993 3,072 1,391 5,668 258 117 476
1994 3,315 1,504 6,092 262 119 482
1995 3,463 1,576 6,337 261 119 478
1996 3,625 1,656 6,602 263 120 479
1997 3,818 1,750 6,915 267 122 483
1998 3,936 1,812 7,088 266 123 480
1999 4,127 1,909 7,385 270 125 484
2000 4,207 1,955 7,477 264 123 470
2001 4,398 2,055 7,762 266 124 470
2002 4,432 2,081 7,766 257 121 451
Tulsa, OK 1992 66 23 182 58 20 161
1993 64 23 178 52 19 144
1994 74 26 204 55 19 150
1995 74 26 204 50 18 137
1996 79 28 218 48 17 132
1997 85 30 236 46 16 127
1998 88 31 243 42 15 116
1999 96 34 266 41 14 113
2000 91 32 251 35 12 98
2001 103 37 283 37 13 101
2002 93 33 257 31 11 85
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Ventura, CA 1992 2,548 1,371 3,778 208 112 308
1993 2,909 1,571 4,298 229 124 339
1994 2,331 1,264 3,431 177 96 261
1995 2,753 1,499 4,036 203 111 298
1996 2,678 1,464 3,908 192 105 280
1997 2,710 1,489 3,936 187 103 271
1998 2,816 1,556 4,068 187 103 269
1999 2,340 1,301 3,360 149 83 214
2000 3,009 1,684 4,295 184 103 263
2001 2,608 1,470 3,700 155 87 220
2002 3,244 1,840 4,571 186 106 263
Washington, DC–MD–VA–WV 1992 472 171 1,274 25 9 68
1993 412 150 1,114 21 7 56
1994 496 180 1,340 23 8 63
1995 464 168 1,252 21 7 56
1996 491 178 1,326 20 7 55
1997 514 186 1,387 20 7 54
1998 540 196 1,455 20 7 53
1999 570 207 1,535 20 7 53
2000 569 207 1,530 18 7 49
2001 604 220 1,623 18 7 49
2002 602 219 1,615 17 6 47
West Palm Beach–Boca Raton, FL 1992 670 257 1,697 125 48 316
1993 531 204 1,342 91 35 230
1994 665 256 1,679 106 41 267
1995 540 208 1,359 79 31 200
1996 545 206 1,329 74 28 181
1997 569 216 1,386 72 27 175
1998 583 221 1,416 69 26 167
1999 699 266 1,692 77 29 186
2000 615 238 1,524 63 24 156
2001 708 275 1,749 67 26 167
2002 650 248 1,558 58 22 138
Metropolitan area Year Number 95 % confidence interval Rate 95 % confidence interval
Lower limit Upper limit Lower limit Upper limit
Wichita, KS 1992 53 19 143 38 14 104
1993 58 21 158 39 14 107
1994 58 21 156 37 13 98
1995 64 23 171 37 13 100
1996 68 24 183 37 13 99
1997 71 26 192 36 13 96
1998 78 28 209 36 13 96
1999 76 27 202 33 12 87
2000 88 32 236 35 13 94
2001 86 31 230 33 12 88
2002 102 37 272 37 14 99
Wilmington–Newark, DE–MD 1992 299 111 757 316 117 799
1993 238 89 604 233 87 591
1994 333 124 842 298 111 753
1995 298 111 754 243 91 615
1996 332 124 839 249 93 628
1997 368 137 928 253 94 639
1998 397 148 999 255 95 641
1999 434 162 1,089 256 96 643
2000 436 163 1,091 239 89 597
2001 454 170 1,131 236 88 589
2002 473 177 1,176 233 87 579
Youngstown–Warren, OH 1992 35 12 99 70 24 199
1993 38 13 107 74 25 208
1994 46 16 128 87 30 241
1995 47 16 130 86 29 237
1996 51 18 143 89 31 250
1997 56 19 156 95 32 264
1998 62 21 173 101 34 281
1999 81 28 224 127 44 351
2000 76 26 210 111 38 308
2001 99 34 273 141 48 389
2002 90 31 249 127 44 350

References

  • 1.Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2008. Vol. 20. Atlanta, GA: Centers for Disease Control and Prevention; 2010.
  • 2.Lelutiu-Weinberger C, Pouget ER, Jarlais DD, et al. A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups. Soc Sci Med. 2009;68(3):579–590. doi: 10.1016/j.socscimed.2008.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Centers for Disease Control and Prevention. HIV/AIDS Surveillance Supplemental Report: Cases of HIV infection and AIDS in the United States, by Race/Ethnicity, 1998–2002. Vol. 10, No. 1. Atlanta, GA: Centers for Disease Control and Prevention; 2003.
  • 4.Huedo-Medina TB, Boynton MH, Warren MR, Lacroix JM, Carey MP, Johnson BT. Efficacy of HIV prevention interventions in Latin American and Caribbean nations, 1995–2008: a meta-analysis. AIDS Behav. 2010;14(6):1237–1251. doi: 10.1007/s10461-010-9763-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Rajabiun S, Rumptz MH, Felizzola J, et al. The impact of acculturation on Latinos' perceived barriers to HIV primary care. Ethn Dis. 2008;18(4):403–408. [PMC free article] [PubMed] [Google Scholar]
  • 6.Darrow WW, Montanea JE, Gladwin H. AIDS-related stigma among Black and Hispanic young adults. AIDS Behav. 2009;13(6):1178–1188. doi: 10.1007/s10461-009-9601-7. [DOI] [PubMed] [Google Scholar]
  • 7.Duran D, Usman HR, Beltrami J, Alvarez ME, Valleroy L, Lyles CM. HIV counseling and testing among Hispanics at CDC-funded sites in the United States, 2007. Am J Public Health. 2010;100(Suppl 1):S152–S158. doi: 10.2105/AJPH.2009.166355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Brady JE, Friedman SR, Cooper HL, Flom PL, Tempalski B, Gostnell K. Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. J Urban Health. 2008;85(3):323–351. doi: 10.1007/s11524-007-9248-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Cooper HLF, Brady JE, Friedman SR, Tempalski B, Gostnell K, Flom PL. Estimating the prevalence of injection drug use among Black and White adults in large US metropolitan areas over time (1992–2002): Estimation methods and prevalence trends. J Urban Health. 2008;85:826–856. doi: 10.1007/s11524-008-9304-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity. Washington: Office of Management and Budget; 1997. [Google Scholar]
  • 11.Office of Management and Budget Standards for defining metropolitan and micropolitan statistical areas. Fed Regist. 2000;65:8228–82238. [Google Scholar]
  • 12.Pierce TG. Gen-X junkie: ethnographic research with young White heroin users in Washington, DC. Subst Use Misuse. 1999;34(14):2095–2114. doi: 10.3109/10826089909039440. [DOI] [PubMed] [Google Scholar]
  • 13.U.S. Bureau of the Census; Population Division. Estimates and Projections Area Methodology County Population Estimates by Age, Sex, Race, and Hispanic Origin for July 1, 2005. Washington, DC: US Bureau of the Census; 2006.
  • 14.HIV Counseling and Testing in Publicly Funded Sites [Computer file] Atlanta: Centers for Disease Control and Prevention; 2008. [Google Scholar]
  • 15.Treatment Episode Data Set [Computer file] Rockville: Substance Abuse and Mental Health Services Administration; 2008. [Google Scholar]
  • 16.AIDS Surveillance Data [Computer file] Atlanta: Centers for Disease Control and Prevention; 2010. [Google Scholar]
  • 17.Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS) Highlight—2007 National Admissions to Substance Abuse Treatment Services. Vol OAS Series #S-45. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2009.
  • 18.SAS/STAT(R) 9.2 User's Guide. 2. Cary: SAS Institute; 2009. [Google Scholar]
  • 19.Friedman SR, Tempalski B, Cooper H, et al. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health. 2004;81(3):377–400. doi: 10.1093/jurban/jth125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;86(5):642–654. doi: 10.2105/AJPH.86.5.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.U.S. Dept. of Health and Human Services, National Vital Statistics System. Multiple Cause of Death, 1992–2002. Washington, DC: U.S. Dept. of Health and Human Services, National Vital Statistics System; 2004.
  • 22.European Monitoring Centre for Drugs and Drug Addiction. EMCDDA Statistical Bulletin 2005. http://stats05.emcdda.europa.eu/en/home-en.html. Accessed January 1, 2011.
  • 23.Broz D, Ouellet LJ. Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic. Drug Alcohol Depend. 2008;94:221–233. doi: 10.1016/j.drugalcdep.2007.11.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Vlahov D, Fuller CM, Ompad DC, Galea S, Jarlais DC. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004;81(1):14–19. doi: 10.1093/jurban/jth083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Centers for Disease Control and Prevention Emergency department visits involving nonmedical use of selected prescription drugs—United States, 2004–2008. MMWR. 2010;59(23):705–709. [PubMed] [Google Scholar]
  • 26.Centers for Disease Control and Prevention HIV/AIDS Among Hispanics—United States, 2001–2005. MMWR. 2007;56(40):1052–1057. [PubMed] [Google Scholar]
  • 27.Diaz T, Buehler JW, Castro KG, Ward JW. AIDS trends among Hispanics in the United States. Am J Public Health. 1993;83:504–509. doi: 10.2105/AJPH.83.4.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Diaz T, Klevens M. Differences by ancestry in sociodemographics and risk. Ethn Dis. 1997;7(3):200–206. [PubMed] [Google Scholar]
  • 29.Substance Abuse and Mental Health Services Administration (SAMSHA); Office of Applied Studies. Hispanic substance abuse treatment admissions: 2003. Rockville, MD: Substance Abuse and Mental Health Services Administration (SAMSHA), Office of Applied Studies; 2005.
  • 30.Robles RR, Matos TD, Colon HM, et al. Determinants of health care use among Puerto Rican drug users in Puerto Rico and New York City. Clin Infect Dis. 2003;37(Suppl 5):S392–S403. doi: 10.1086/377552. [DOI] [PubMed] [Google Scholar]
  • 31.Estrada AL. Drug use and HIV risks among African-American, Mexican-American, and Puerto Rican drug injectors. J Psychoactive Drugs. 1998;30(3):247–253. doi: 10.1080/02791072.1998.10399699. [DOI] [PubMed] [Google Scholar]
  • 32.Borges G, Medina-Mora ME, Breslau J, Aguilar-Gaxiola S. The effect of migration to the United States on substance use disorders among returned Mexican migrants and families of migrants. Am J Public Health. 2007;97(10):1847–1851. doi: 10.2105/AJPH.2006.097915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Montoya ID, Bell DC, Richard AJ, Carlson JW, Trevino RA. Estimated HIV risk among Hispanics in a national sample of drug users. J Acquir Immune Defic Syndr. 1999;21(1):21–50. doi: 10.1097/00126334-199905010-00006. [DOI] [PubMed] [Google Scholar]
  • 34.Colón HM, Robles RR, Deren S, et al. Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamon, Puerto Rico. J Acquir Immune Defic Syndr. 2001;27(4):405–413. doi: 10.1097/00042560-200108010-00012. [DOI] [PubMed] [Google Scholar]
  • 35.Delgado M, Lundgren LM, Deshpande A, Lonsdale J, Purington T. The association between acculturation and needle sharing among Puerto Rican injection drug users. Eval Program Plann. 2008;31(1):83–91. doi: 10.1016/j.evalprogplan.2007.05.010. [DOI] [PubMed] [Google Scholar]
  • 36.U.S. Census Bureau. Table 4. Difference in Population by Race and Hispanic or Latino Origin, for the United States: 1990 to 2000. Washington, DC: U.S. Census Bureau; 2001.
  • 37.Freeman K, Zonszein J, Islam N, Blank AE, Strelnick AH. Mortality trends and disparities among racial/ethnic and sex subgroups in New York City, 1990 to 2000. J Immigr Minor Health. 2010;13(3):546–554. doi: 10.1007/s10903-010-9345-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Freeman RC, Williams ML, Saunders LA. Drug use, AIDS knowledge, and HIV risk behaviors of Cuban-, Mexican-, and Puerto-Rican-born drug injectors who are recent entrants into the United States. Subst Use Misuse. 1999;34(13):1765–1793. doi: 10.3109/10826089909039426. [DOI] [PubMed] [Google Scholar]
  • 39.Cooper HLF, Friedman S, Tempalski B, Friedman R, Keem M. Racial/ethnic disparities in injection drug use in 94 U.S. metropolitan statistical areas in 1998. Ann Epidemiol. 2005;15(5):326–334. doi: 10.1016/j.annepidem.2004.10.008. [DOI] [PubMed] [Google Scholar]
  • 40.Gonzalez JS, Hendriksen ES, Collins EM, Duran RE, Safren SA. Latinos and HIV/AIDS: examining factors related to disparity and identifying opportunities for psychosocial intervention research. AIDS Behav. 2009;13(3):582–602. doi: 10.1007/s10461-008-9402-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES